US EditionSOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development
2 Articles
2 Articles
SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing and Cell Engineering is pleased to acknowledge recent FDA…
Researchers in Mexico are urging the government to authorize the use of gene-editing tools like CRISPR to improve crops. They are requesting regulations that distinguish gene editing from genetically modified organisms (GMOs), as is already the case in other Latin American countries. They warn that Mexico could fall behind and are promoting science-based policies to develop more resilient and nutritious crops. The post Mexico: Researchers reques…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
